OCULAR THERAPEUTIX, INC Notes Payable, Current
OCULAR THERAPEUTIX, INC (OCUL) had Notes Payable, Current of $2.08 million as of 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2023-08-07
- 2023-06-30: Notes Payable, Current $2.08M.
- 2021-03-31: Notes Payable, Current $8.29M.
- 2020-12-31: Notes Payable, Current $8.29M.
- 2020-09-30: Notes Payable, Current $6.21M.
| Period end | Notes Payable, Current |
|---|---|
| 2023-06-30 | $2.08M 10-Q · filed 2023-08-07 |
| 2021-03-31 | $8.29M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $8.29M 10-K · filed 2022-02-28 |
| 2020-09-30 | $6.21M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.15M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $2.07M 10-Q · filed 2020-05-08 |
| 2018-09-30 | $6.09M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $6.08M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $6.07M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $5.54M 10-K · filed 2019-03-07 |
| 2017-09-30 | $3.99M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $2.44M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $897.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $1.55M 10-K · filed 2018-03-08 |
| 2016-09-30 | $3.77M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.47M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.16M 10-Q · filed 2016-05-10 |
| 2015-09-30 | $5.88M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $4.37M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $2.86M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $1.35M 10-K · filed 2016-03-10 |
| 2014-06-30 | $1.08M 10-Q · filed 2014-08-29 |
| 2013-12-31 | $1.81M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |